DermaPure® Decellularized Dermal Allograft
Printer-friendly version
DermaPure® is 99% DNA-free decellularized human dermis. Intact vascular-like channels and native growth factors stimulate revascularization and signal a biologic response for wound healing.
• Produced using patented dCELL® Technology
• Human-derived dermal allograft
• Minimally manipulated to maintain structure
• 99% DNA-free
• Biocompatible while retaining native growth factors, collagen, and elastin preserving natural structure
• Replaces the damaged extracellular matrix so living cells can flourish
• Supports angiogenesis with the presence of vascular-like channels present prior to application
• Permits fibroblasts to attach to the scaffold
• Contains the correct extracellular matrix components to attract and proliferate endothelial cells
DermaPure® Decellularized Dermal Allograft provides a scaffold for the body’s repair or replacement of damaged or inadequate integumental tissue or for other homologous uses of human integument.
See package insert/Instructions for Use.
See package insert/Instructions for Use.
Ambient temperature.
Decellularized human dermis
| Assigned HCPCS code | ● |
| Cryopreserved | |
| Dehydrated | |
| Desiccated | |
| Flowable | |
| Micronized | |
| Sheet form | ● |
| Requires refrigeration | |
| Shelf life greater than 2 years | |
| Shelf life limited | |
| Indicated for acute wounds | |
| Indicated for chronic wounds | |
| Indicated for diabetic ulcers | |
| Indicated for pressure ulcers | |
| Indicated for surgical wounds | |
| Indicated for third-degree burns | |
| Indicated for venous ulcers | |
| Contact manufacturer for usage guidelines | ● |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available | ● |
Acute Wounds
Chronic Wounds
Single application in most cases. Additional applications at physician discretion.
Primary dressing: Non-adherent contact layer. Bolster: Normal saline-moistened gauze or hydrogel-moistened gauze. Secondary dressing: Maintain a moist wound environment with a foam dressing.
Tissue Regenix is an innovative company in the field of regenerative medicine. The potential technology applications can address clinical needs such as wound care, vascular disease, heart valve replacement and knee repair.